Prevalence of Eye Toxicities in Patients With Cancer Is Much

In the real-world setting, cases of ocular adverse effects have emerged with greater frequency both in new and established therapies than has been previously observed in many clinical trials.

Related Keywords

Ohio , United States , Shahzad Raza , Investigators At Cleveland Clinic Taussig Cancer Center , Department Of Hematology , Oncology At Cleveland Clinic Taussig Cancer Center , Cleveland Clinic Taussig Cancer Center , Medical Oncology , D , Eye Toxicities , Monoclonal Antibodies , Mmunotherapies , Antibody Drug Conjugates , Growth Factor Receptors , Checkpoint Inhibitors , Nd Targeted Therapies ,